Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01890031 · ClinicalTrials.gov registry record · Phase 1
Interactive Cholesterol Advisory Tool
A Phase 1 study, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 1
- Development phase
- 131
- Enrollment target
NCT01890031: Completed Phase 1 study, sponsored by University of Rochester.
NCT01890031 is a Phase 1 study that has completed, run by University of Rochester. The registered enrollment target is 131 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (118% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01890031, a Phase 1 study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 131 participants
- Enrollment target
Study Summary
The purpose of this study is to show that we can effectively deliver health information and education, online, via computer regarding cholesterol. This computer program is called the Interactive Cholesterol Advisory Tool (ICAT).
Interventions
- OTHER Interactive Cholesterol Advisory Tool
- OTHER Study physician visits
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2012-01 |
| Est. Completion | 2013-06 |
| Phase | Phase 1 |
What the finished NCT01890031 record still lists
NCT01890031 is an interventional study that assigns participants to a tested intervention. The registered 131 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (118% higher).
The record links to 0 conditions, and to 2 interventions - of which Interactive Cholesterol Advisory Tool is the first listed.
NCT01890031 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01890031 about?
NCT01890031 is a clinical study titled "Interactive Cholesterol Advisory Tool". The purpose of this study is to show that we can effectively deliver health information and education, online, via computer regarding cholesterol. This computer program is called the Interactive Cholesterol Advisory Tool (ICAT).
What is the current status of trial NCT01890031?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 131 participants. The study started on 2012-01. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01890031?
The interventions under investigation include: Interactive Cholesterol Advisory Tool (OTHER), Study physician visits (OTHER).
Who is sponsoring clinical trial NCT01890031?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01890031's enrollment target sits among peer trials
131 439th of 2000 higher than 1,562 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03051464 · 131 participants · Phase 2
No Surgery Trial / Two Dose-escalation Strategies
- NCT04301843 · 131 participants · Phase 2
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
- NCT04748549 · 131 participants · NA
Intraoperative VR for Older Patients Undergoing TKA
- NCT05951179 · 131 participants · Phase 2
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia